Ladenburg Thalmann Financial Services’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
Ladenburg Thalmann Financial Services's NVAX Position: Q4 2019 in Review
Ladenburg Thalmann Financial Services increased its Novavax (NVAX) stake by 37% in Q4 2019, buying an estimated $50.5K and bringing the position to 43,392 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #2617.
Ladenburg Thalmann Financial Services first reported a position in NVAX in Q2 2013 and has held it in 27 quarters since. The position peaked at $267K in Q4 2018. 77 funds tracked by Wall St. Rank hold NVAX as of Q4 2019.
- Ladenburg Thalmann Financial Services held 43,392 shares of Novavax worth $173K as of Q4 2019.
- Ladenburg Thalmann Financial Services bought 11,645 Novavax shares in Q4 2019, an estimated $50.5K.
- Novavax made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2617 holding.
- Ladenburg Thalmann Financial Services first reported a position in Novavax in Q2 2013 and has held it in 27 quarters since.
- Ladenburg Thalmann Financial Services's Novavax position peaked at $267K in Q4 2018.
- 77 funds tracked by Wall St. Rank held Novavax as of Q4 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.